ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Hovione Announces Successful End-of-Phase 2 Meeting with the FDA
September 23, 2019Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea. -
Motif Bio Announces Path Forward for Iclaprim following Receipt of FDA Meeting Minutes
June 13, 2019Motif Bio Announces Path Forward for Iclaprim following Receipt of FDA Meeting Minutes. -
Roche Annual General Meeting 2017
March 15, 2017Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its shareholders approved all proposals of the Board of Directors at its ordinary Annual General Meeting (AGM).
Pharma Sources Insight January 2025
